GlassScriptPhysician profile
Ashley Michelle Dewitt
NPI 1043476757
$9,058.16
in general payments reported to CMS, 2019-2025
29 companies · $7,231 in 2025
The $7,231 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $151 · 2021: $219 · 2022: $299 · 2023: $512 · 2024: $536 · 2025: $7,231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,099 · Food and Beverage: $1,614 · Travel and Lodging: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,099.00 |
| Food and Beverage | $1,613.56 |
| Travel and Lodging | $566.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,583.29 | 2025 | |
| Boston Scientific Corporation | $471.15 | 2020-2025 | Solyx Sis System, Advantage System, Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous) |
| Astellas Pharma US INC | $383.84 | 2023-2025 | Veozah |
| Novo Nordisk INC | $252.17 | 2020-2023 | Wegovy |
| Abbvie INC. | $210.33 | 2019-2024 | Orilissa, Lo Loestrin Fe |
| Axonics, INC. | $207.57 | 2023-2024 | Axonics, Bulkamid |
| Sage Therapeutics, LLC | $170.24 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $135.45 | 2020-2025 | Slynd |
| Aspira Women'S Health INC | $120.67 | 2021-2022 | |
| Hologic Sales and Service, LLC | $68.36 | 2021-2024 | Fluent Fluid Management System, Novasure |
| Bayer Healthcare Pharmaceuticals INC. | $57.47 | 2019-2022 | |
| Organon LLC | $43.79 | 2024-2025 | Nexplanon |
| Minerva Surgical, INC | $42.34 | 2019-2024 | |
| Coopersurgical, INC. | $35.73 | 2022 | |
| Shield Therapeutics INC | $33.65 | 2024-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $32.74 | 2019-2025 | Olympus |
| Pfizer INC. | $23.55 | 2024 | |
| Coloplast Corp | $22.14 | 2024 | |
| Therapeuticsmd, INC. | $18.38 | 2022 | |
| Sumitomo Pharma America, INC. | $18.36 | 2025 | Myfembree |
| Duchesnay USA Incorporated | $16.94 | 2019 | |
| Optumhealth Care Solutions, LLC | $15.90 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Pacira Pharmaceuticals Incorporated | $15.56 | 2023 | Exparel |
| Medtronic, INC. | $14.68 | 2025 | Truclear |
| Daiichi Sankyo INC. | $14.18 | 2021 | |
| Smith+Nephew, INC. | $13.65 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.23 | 2023 | Seglentis |
| Mylan Pharmaceuticals INC. | $11.64 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Dewitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.